Innoviva (INVA) Surges After Record Q3 2025 Earnings
Innoviva Inc. (NASDAQ:INVA) is a diversified healthcare and biopharmaceutical company based in Burlingame, California, known for its strong…
Why Analysts See Guardant Health (GH) Rallying to $249
Guardant Health Inc. (NASDAQ:GH) is a leading precision oncology company headquartered in Palo Alto, California, dedicated to transforming…
Tectonic Therapeutic (TECX) Gets Bullish Boost — Analysts Predict 330% Rally
Tectonic Therapeutic Inc. (NASDAQ:TECX) is a pioneering biotechnology company focused on unlocking the full therapeutic potential of G-protein-coupled…
VivoSim Labs (VIVS) Surges 19.8% After Clinical Trial Breakthrough
VivoSim Labs Inc. (NASDAQ:VIVS) is an emerging biotechnology company pioneering the next generation of non-animal, simulation-based testing solutions…
Why Indivior (INDV) Just Raised 2025 Revenue Guidance to $1.18-$1.22B
Indivior plc (NASDAQ:INDV) is a global specialty biopharmaceutical company best known for pioneering science and access models in…
Why EDAP TMS (EDAP) Could Be the Next $2B MedTech Breakout
EDAP TMS S.A. (NASDAQ:EDAP) is a pioneering global medical technology company specializing in the development, manufacturing, and commercialization…
Anbio Biotechnology (NNNN) Surges 142% in 2025
Anbio Biotechnology Inc. (NASDAQ:NNNN) has quickly become one of the most closely watched small-cap biotech stocks on Wall…
Why Glaukos (GKOS) Could Surge 30% in 2025
Glaukos Corporation (NYSE:GKOS) remains one of the most innovative and disruptive players in the ophthalmic medical technology sector,…
Pfizer vs Novo Nordisk: The $10B War Over Metsera (MTSR)
Metsera Inc. (NASDAQ: MTSR) is a next-generation biotechnology company pioneering innovative therapies for obesity and metabolic diseases through…
Immuron (IMRN) Raises $8.5M for Biotech Expansion
Immuron Limited (NASDAQ:IMRN) is an Australia-based biopharmaceutical company focused on developing and commercializing innovative oral immunotherapies that target…
ImageneBio (IMA) Targets 3,634% Upside
ImageneBio Inc. (NASDAQ:IMA) is a clinical-stage biopharmaceutical company dedicated to developing next-generation therapies for immunological and inflammatory diseases…
4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside
4D Molecular Therapeutics Inc. (NASDAQ:FDMT) is a clinical-stage biopharmaceutical company pioneering a new generation of genetic medicines through…
Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake
Neumora Therapeutics Inc. (NASDAQ:NMRA) is a clinical-stage biotechnology company singularly focused on transforming the treatment of brain diseases…
Euda Health (EUDA) Launches Strategic India Partnership
Euda Health Holdings Limited (NASDAQ:EUDA) is a Singapore-based healthcare technology company focused on transforming the delivery of preventive…
Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company
Kyverna Therapeutics Inc. (NASDAQ:KYTX) is a clinical-stage biopharmaceutical company focused on transforming the treatment paradigm for autoimmune diseases…
Creative Medical (CELZ) Narrows Loss by 21% and Shares Jump 14%
Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) is a clinical-stage biotechnology company pioneering breakthrough regenerative medicine and cell-based technologies…
Gossamer Bio (GOSS) Targets $7 Billion PAH Market
Gossamer Bio Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company founded with a mission to develop breakthrough therapies targeting…
Clover Health (CLOV) Surges 19% After Buy Rating
Clover Health Investments Corp. (NASDAQ:CLOV) is a next-generation health technology company transforming the U.S. healthcare system through its…